BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25535686)

  • 1. Sequence-defined polymers for the delivery of oligonucleotides.
    Lehto T; Wagner E
    Nanomedicine (Lond); 2014 Dec; 9(18):2843-59. PubMed ID: 25535686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide nanoparticles for oligonucleotide delivery.
    Lehto T; Ezzat K; Langel U
    Prog Mol Biol Transl Sci; 2011; 104():397-426. PubMed ID: 22093225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymers for nucleic acid transfer-an overview.
    Wagner E
    Adv Genet; 2014; 88():231-61. PubMed ID: 25409608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.
    Margus H; Padari K; Pooga M
    Mol Ther; 2012 Mar; 20(3):525-33. PubMed ID: 22233581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise.
    Wagner E
    Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-based in vivo delivery agents for oligonucleotides and siRNA.
    Coursindel T; Järver P; Gait MJ
    Nucleic Acid Ther; 2012 Apr; 22(2):71-6. PubMed ID: 22409235
    [No Abstract]   [Full Text] [Related]  

  • 8. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
    Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
    J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies and advances in nanomedicine for targeted siRNA delivery.
    Nimesh S; Gupta N; Chandra R
    Nanomedicine (Lond); 2011 Jun; 6(4):729-46. PubMed ID: 21718181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of therapeutic oligonucleotides with cell penetrating peptides.
    Boisguérin P; Deshayes S; Gait MJ; O'Donovan L; Godfrey C; Betts CA; Wood MJ; Lebleu B
    Adv Drug Deliv Rev; 2015 Jun; 87():52-67. PubMed ID: 25747758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
    Gary DJ; Puri N; Won YY
    J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
    Kang H; DeLong R; Fisher MH; Juliano RL
    Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers.
    Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J
    Mol Pharm; 2013 Jun; 10(6):2435-44. PubMed ID: 23611705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Click conjugated polymeric immuno-nanoparticles for targeted siRNA and antisense oligonucleotide delivery.
    Chan DP; Deleavey GF; Owen SC; Damha MJ; Shoichet MS
    Biomaterials; 2013 Nov; 34(33):8408-15. PubMed ID: 23932248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles for siRNA delivery: Production and applications.
    Cavallaro G; Sardo C; Craparo EF; Porsio B; Giammona G
    Int J Pharm; 2017 Jun; 525(2):313-333. PubMed ID: 28416401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
    Zhao X; Pan F; Holt CM; Lewis AL; Lu JR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):673-86. PubMed ID: 19552611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of siRNA delivery by nanoparticles.
    Yuan X; Naguib S; Wu Z
    Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.